We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$4.25B
1-Year Est. Return
141.71%
This Fund
S&P 500
This Quarter
Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
(+34%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LGN
Legence Corp
LGN
|
+$53.3M |
| 2 |
Sensient Technologies
SXT
|
+$43.9M |
| 3 |
InterDigital
IDCC
|
+$35.5M |
| 4 |
Axcelis
ACLS
|
+$34.7M |
| 5 |
Terex
TEX
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$137M |
| 2 |
Credo Technology Group
CRDO
|
+$94.7M |
| 3 |
TTM Technologies
TTMI
|
+$85.3M |
| 4 |
Fabrinet
FN
|
+$68.7M |
| 5 |
Sterling Infrastructure
STRL
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Industrials | 24.1% |
| 3 | Healthcare | 21.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 9.02% |
No holdings matched the selected filter criteria.
Similar funds
AP
QWP
HMC
SCA
MA
TFM
IAA
CAM
Emerald Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
- Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
- Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
- Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
- Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
- Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
- Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.